In accordance with in vitro study, RT-qPCR data revealed that COFE administration significantly suppressed the mRNA expression of PCNA compared to that of the testosterone-induced BPH group (Figure 4A). The gene discussed is PCNA; the disease is benign prostatic hyperplasia.